1. Rationale for Therapy Discontinuation in Patients with Lower-Risk Transfusion-Dependent Myelodysplastic Syndromes (LR-MDS). (April 2017) Authors: Gerds, A.T.; Gupta, S.; Sekeres, M.A.; Nazha, A.; Carraway, H.E.; Hawthorne, S.; King-Concialdi, K.; McGuire, M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗